comparemela.com

Latest Breaking News On - Ivan marazzi - Page 3 : comparemela.com

UTMB scientists awarded $11 3 million for new studies on Ebola virus

 E-Mail GALVESTON, TEXAS - Researchers at the University of Texas Medical Branch at Galveston have been awarded an $11.3 Million, multi-year grant from the National Institute of Allergy and Infectious Diseases to study immunopathogenesis of Ebola, and in particular to determine why cells infected with Ebola develop immune system paralysis, which inhibits immune response, leads to hyperinflammation, and allows the deadly infection to spread. The research will be led by Co-Principal Investigators Alexander Bukreyev, PhD, of UTMB s Department of Pathology, and Mariano Garcia-Blanco, MD, PhD, Chair of the Biochemistry and Molecular Biology Department. While some might question, Why Ebola now? Dr. Bukreyev explains that, while the COVID-19 pandemic has grabbed headlines and been a primary focus for researchers worldwide for the last 18 months, scientists at UTMB have never stopped working to increase their understanding of Ebola as part of a global effort to develop effective medic

Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study

Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study Toggle share menu Advertisement Cancer drug may be able to treat inflammation caused by COVID-19 virus: Singapore-US study Dr Anand Jeyasekharan with a vial of Topotecan, a cancer drug that could potentially be used in the treatment of COVID-19. (Photo: National University Cancer Institute, Singapore) 07 Apr 2021 09:50PM) Share this content Bookmark SINGAPORE: A widely available and inexpensive drug used for cancer treatment could potentially be used in the treatment of COVID-19, according to a study by Singapore and US researchers.  They found that the chemotherapeutic drug, called Topotecan, reduced the severity and death rates of infection by the virus that causes COVID-19, by suppressing inflammation in the lungs of laboratory animals.

Even after late start, anti-inflammatory drug protects against lethal inflammation from COVID

Even after late start, anti-inflammatory drug protects against lethal inflammation from COVID
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.